{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T13:43:26Z","timestamp":1790257406677,"version":"4.1.0"},"reference-count":48,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.3892\/ijo.2016.3382","type":"journal-article","created":{"date-parts":[[2016,2,8]],"date-time":"2016-02-08T07:53:54Z","timestamp":1454918034000},"page":"1710-1720","source":"Crossref","is-referenced-by-count":37,"title":["Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells"],"prefix":"10.3892","volume":"48","author":[{"given":"WEI","family":"HE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIUJIN","family":"YE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIANBO","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEN","family":"LEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LIANGSHUN","family":"YOU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LEI","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIAOHUI","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WENBIN","family":"QIAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,2,8]]},"reference":[{"key":"key20180107185116_b1-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev.me.40.020189.000553","article-title":"Molecular pathogenesis of Ph-positive leukemias","volume":"40","author":"Clark","year":"1989","journal-title":"Annu Rev Med"},{"key":"key20180107185116_b2-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"503","DOI":"10.18388\/abp.2013_2014","article-title":"Role of anti-apoptotic pathways activated by BCR\/ABL in the resistance of chronic myeloid leukemia cells to tyrosine kinase inhibitors","volume":"60","author":"Danisz","year":"2013","journal-title":"Acta Biochim Pol"},{"key":"key20180107185116_b3-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.leu.2403241","article-title":"JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis","volume":"18","author":"Steelman","year":"2004","journal-title":"Leukemia"},{"key":"key20180107185116_b4-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1093\/emboj\/16.20.6151","article-title":"Transformation of hematopoietic cells by BCR\/ABL requires activation of a PI-3k\/Akt-dependent pathway","volume":"16","author":"Skorski","year":"1997","journal-title":"EMBO J"},{"key":"key20180107185116_b5-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1038\/sj.onc.1203486","article-title":"STAT signaling in the pathogenesis and treatment of leukemias","volume":"19","author":"Lin","year":"2000","journal-title":"Oncogene"},{"key":"key20180107185116_b6-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"key20180107185116_b7-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa055229","article-title":"Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias","volume":"354","author":"Talpaz","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180107185116_b8-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa055104","article-title":"Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL","volume":"354","author":"Kantarjian","year":"2006","journal-title":"N Engl J Med"},{"key":"key20180107185116_b9-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s40265-014-0216-6","article-title":"Ponatinib: A review of its use in adults with chronic myeloid leukaemia or Philadelphia chromosome-positive acute lymphoblastic leukaemia","volume":"74","author":"Hoy","year":"2014","journal-title":"Drugs"},{"key":"key20180107185116_b10-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1056\/NEJMoa1205127","article-title":"Ponatinib in refractory Philadelphia chromosome-positive leukemias","volume":"367","author":"Cortes","year":"2012","journal-title":"N Engl J Med"},{"key":"key20180107185116_b11-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2174\/156800907780809778","article-title":"Hsp90: A novel target for the disruption of multiple signaling cascades","volume":"7","author":"Bishop","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"key":"key20180107185116_b12-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1535-6108(03)00029-1","article-title":"Heat shock protein 90 as a molecular target for cancer therapeutics","volume":"3","author":"Isaacs","year":"2003","journal-title":"Cancer Cell"},{"key":"key20180107185116_b13-ijo-48-04-1710","first-page":"1799","article-title":"Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts","volume":"61","author":"Nimmanapalli","year":"2001","journal-title":"Cancer Res"},{"key":"key20180107185116_b14-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"19","DOI":"10.18632\/genesandcancer.49","article-title":"HSP90 inhibitor AUY922 induces cell death by disruption of the Bcr-Abl, Jak2 and HSP90 signaling network complex in leukemia cells","volume":"6","author":"Tao","year":"2015","journal-title":"Genes Cancer"},{"key":"key20180107185116_b15-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/leu.2008.89","article-title":"Disruption of the Bcr-Abl\/Hsp90 protein complex: A possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin","volume":"22","author":"Wu","year":"2008","journal-title":"Leukemia"},{"key":"key20180107185116_b16-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/s10637-010-9465-8","article-title":"The synthetic heat shock protein 90 (Hsp90) inhibitor EC141 induces degradation of Bcr-Abl p190 protein and apoptosis of Ph-positive acute lymphoblastic leukemia cells","volume":"29","author":"Tong","year":"2011","journal-title":"Invest New Drugs"},{"key":"key20180107185116_b17-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/1535-7163.MCT-08-0758","article-title":"BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90","volume":"8","author":"Lundgren","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"key20180107185116_b18-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/ijc.24825","article-title":"BIIB021, a synthetic Hsp90 inhibitor, has broad application against tumors with acquired multidrug resistance","volume":"126","author":"Zhang","year":"2010","journal-title":"Int J Cancer"},{"key":"key20180107185116_b19-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"e1003048","DOI":"10.1371\/journal.ppat.1003048","article-title":"Hsp90 inhibitors are efficacious against Kaposi Sarcoma by enhancing the degradation of the essential viral gene LANA, of the viral co-receptor EphA2 as well as other client proteins","volume":"8","author":"Chen","year":"2012","journal-title":"PLoS Pathog"},{"key":"key20180107185116_b20-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fmicb.2015.00280","article-title":"The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas","volume":"6","author":"Suzuki","year":"2015","journal-title":"Front Microbiol"},{"key":"key20180107185116_b21-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1158\/1078-0432.CCR-13-1257","article-title":"A phase 1, dose-escalation, pharmacokinetic and pharmacodynamic study of BIIB021 administered orally in patients with advanced solid tumors","volume":"20","author":"Saif","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key20180107185116_b22-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/annonc\/mds275","article-title":"Phase II study of the HSP90-inhibitor BIIB021 in gastrointestinal stromal tumors","volume":"24","author":"Dickson","year":"2013","journal-title":"Ann Oncol"},{"key":"key20180107185116_b23-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.3892\/etm.2014.1651","article-title":"BIIB021, an Hsp90 inhibitor, effectively kills a myelodysplastic syndrome cell line via the activation of caspases and inhibition of PI3K\/Akt and NF-\u03baB pathway proteins","volume":"7","author":"Lin","year":"2014","journal-title":"Exp Ther Med"},{"key":"key20180107185116_b24-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/aps.2013.124","article-title":"Hsp90 inhibitor BIIB021 enhances triptolide-induced apoptosis of human T-cell acute lymphoblastic leukemia cells in vitro mainly by disrupting p53-MDM2 balance","volume":"34","author":"Li","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"key20180107185116_b25-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.leukres.2006.06.021","article-title":"Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1","volume":"31","author":"Qian","year":"2007","journal-title":"Leuk Res"},{"key":"key20180107185116_b26-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.stem.2012.02.017","article-title":"Genetic and pharmacologic inhibition of \u03b2-catenin targets imatinib-resistant leukemia stem cells in CML","volume":"10","author":"Heidel","year":"2012","journal-title":"Cell Stem Cell"},{"key":"key20180107185116_b27-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/sj.emboj.7601485","article-title":"Bcr-Abl stabilizes beta-catenin in chronic myeloid leukemia through its tyrosine phosphorylation","volume":"26","author":"Coluccia","year":"2007","journal-title":"EMBO J"},{"key":"key20180107185116_b28-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3892\/ijo.2014.2727","article-title":"Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cells","volume":"46","author":"Mori","year":"2015","journal-title":"Int J Oncol"},{"key":"key20180107185116_b29-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1186\/1476-4598-13-230","article-title":"Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer","volume":"13","author":"Del Bufalo","year":"2014","journal-title":"Mol Cancer"},{"key":"key20180107185116_b30-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1158\/0008-5472.CAN-10-4475","article-title":"Following cytochrome c release, autophagy is inhibited during chemotherapy-induced apoptosis by caspase 8-mediated cleavage of Beclin 1","volume":"71","author":"Li","year":"2011","journal-title":"Cancer Res"},{"key":"key20180107185116_b31-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1038\/cddis.2009.16","article-title":"Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria","volume":"1","author":"Wirawan","year":"2010","journal-title":"Cell Death Dis"},{"key":"key20180107185116_b32-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ceb.2009.11.014","article-title":"Mammalian autophagy: Core molecular machinery and signaling regulation","volume":"22","author":"Yang","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"key20180107185116_b33-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat Cell Biol"},{"key":"key20180107185116_b34-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1182\/blood-2006-10-054098","article-title":"Inhibition of heat shock protein 90 prolongs survival of mice with BCR-ABL-T315I-induced leukemia and suppresses leukemic stem cells","volume":"110","author":"Peng","year":"2007","journal-title":"Blood"},{"key":"key20180107185116_b35-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.leu.2404533","article-title":"Different target range and cytotoxic specificity of adaphostin and 17-allylamino-17-demethoxygeldanamycin in imatinib-resistant and sensitive cell lines","volume":"21","author":"Barnes","year":"2007","journal-title":"Leukemia"},{"key":"key20180107185116_b36-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1172\/JCI26321","article-title":"Pharmacological manipulation of cell death: Clinical applications in sight?","volume":"115","author":"Green","year":"2005","journal-title":"J Clin Invest"},{"key":"key20180107185116_b37-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1182\/blood-2012-01-402578","article-title":"Autophagic degradation of the BCR-ABL oncoprotein and generation of antileukemic responses by arsenic trioxide","volume":"120","author":"Goussetis","year":"2012","journal-title":"Blood"},{"key":"key20180107185116_b38-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ajh.23428","article-title":"Induction of autophagy by Imatinib sequesters Bcr-Abl in autophagosomes and down-regulates Bcr-Abl protein","volume":"88","author":"Elzinga","year":"2013","journal-title":"Am J Hematol"},{"key":"key20180107185116_b39-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"key20180107185116_b40-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2002-09-2780","article-title":"Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment","volume":"101","author":"Bhatia","year":"2003","journal-title":"Blood"},{"key":"key20180107185116_b41-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1172\/JCI68951","article-title":"PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells","volume":"123","author":"Neviani","year":"2013","journal-title":"J Clin Invest"},{"key":"key20180107185116_b42-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/aps.2011.192","article-title":"Perifosine induces protective autophagy and upregulation of ATG5 in human chronic myelogenous leukemia cells in vitro","volume":"33","author":"Tong","year":"2012","journal-title":"Acta Pharmacol Sin"},{"key":"key20180107185116_b43-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/cdd.2008.107","article-title":"The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias","volume":"15","author":"Kamitsuji","year":"2008","journal-title":"Cell Death Differ"},{"key":"key20180107185116_b44-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1182\/blood-2011-01-330621","article-title":"Kill one bird with two stones: Potential efficacy of BCR-ABL and autophagy inhibition in CML","volume":"118","author":"Helgason","year":"2011","journal-title":"Blood"},{"key":"key20180107185116_b45-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1179\/102453311X12902908412039","article-title":"Imatinib induces autophagy through BECLIN-1 and ATG5 genes in chronic myeloid leukemia cells","volume":"16","author":"Can","year":"2011","journal-title":"Hematology"},{"key":"key20180107185116_b46-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/leu.2011.339","article-title":"The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia","volume":"26","author":"Willems","year":"2012","journal-title":"Leukemia"},{"key":"key20180107185116_b47-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1158\/1078-0432.CCR-13-3218","article-title":"Autophagy is a survival mechanism of acute myelogenous leukemia precursors during dual mTORC2\/mTORC1 targeting","volume":"20","author":"Altman","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key20180107185116_b48-ijo-48-04-1710","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3324\/haematol.2009.013797","article-title":"Role of the PI3K\/AKT and mTOR signaling pathways in acute myeloid leukemia","volume":"95","author":"Park","year":"2010","journal-title":"Haematologica"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2016.3382\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T06:57:41Z","timestamp":1718348261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2016.3382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,8]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,2,8]]},"published-print":{"date-parts":[[2016,4]]}},"alternative-id":["10.3892\/ijo.2016.3382"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2016.3382","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,8]]}}}